智通财经APP获悉，东阳光长江药业(01558)涨超6%，截至发稿，涨6.54%，报9.94港元，成交额2108.47万港元。
消息面上，据中国疾控中心最新数据，目前流感病毒阳性率持续上升，其99%以上为甲流。叮当快药数据显示，近一个月内，抗流感药品奥司他韦及速福达，销售增长率高达164%。
东阳光长江药业是一家专注于抗病毒、内分泌及代谢性疾病、心血管疾病等治疗领域产品开发、生产及销售的中国制药企。主要产品包括抗流感药可威（磷酸奥司他韦胶囊和颗粒）等。从企业销售情况看，2023年共有27家企业在样本终端市场销售奥司他韦制剂。其中，宜昌东阳光长江药业以65.01%的销售额占比位居第一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.